Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia

American Journal of Medical Genetics, Part A

Volumn 167, Issue 1, 2015, Pages 69-79

  Kweh, Frederick A ^a   Miller, Jennifer L ^a   Sulsona, Carlos R ^a   Wasserfall, Clive ^a   Atkinson, Mark ^a   Shuster, Jonathan J ^b   Goldstone, Anthony P ^a,c   Driscoll, Daniel J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Ghrelin; Hyperghrelinemia; Hyperphagia; Nutritional phase; Obesity; Prader Willi

Indexed keywords

GHRELIN; GROWTH HORMONE; INSULIN; LEPTIN;

ADOLESCENT; ADULT; ARTICLE; BODY FAT; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF HORMONE METABOLISM; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HYPERGHRELINEMIA; HYPERPHAGIA; INFANT; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NEWBORN; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; WEIGHT HEIGHT RATIO; YOUNG ADULT; AGE DISTRIBUTION; BLOOD; CLASSIFICATION; DIET RESTRICTION; INSULIN RESISTANCE; SIBLING;

AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FASTING; FEMALE; GHRELIN; HUMANS; HYPERPHAGIA; INFANT; INSULIN RESISTANCE; MALE; OBESITY, MORBID; PRADER-WILLI SYNDROME; SIBLINGS; YOUNG ADULT;

EID: 84919685912     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36810     Document Type: Article

References (46)

1. Abdel Hakeem AH, Saed SZ, El Rehany MA, Yassin EE. 2012. Serum level of ghrelin in umbilical cord in small and appropriate for gestational age newborn infants and its relationship to anthropometric measures. J Clin Neonatol 1:135-138.
2. Ariyasu H, Takaya K, Hosoda H, Iwakura H. 2002. Delayed short-term secretory regulation of ghrelin in obese animals: Evidenced by a specific RIA for the active form of ghrelin. Endocrinol 143:3341-3350.
3. Bellone S, Baldelli R, Radetti G, Rapa A, Vivenza D, Petri A, Savastio S, Zaffaroni M, Broglio F, Ghigo E, Bona G. 2006. Ghrelin secretion in preterm neonates progressively increases and is refractory to the inhibitory effect of food intake. J Clin Endocrinol Metab 91:1929-1933.
4. Bellone S, Castellino N, Broglio F, Rapa A, Vivenza D, Radetti G, Bellone J, Gottero C, Ghigo E, Bona G. 2004. Ghrelin secretion in childhood is refractory to the inhibitory effect of feeding. J Clin Endocrinol Metab 89:1662-1665.
5. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. 2002. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: A population-based study. Dev Med Child Neurol 44:248-255.
6. Butler JV, Whittington JE, Holland AJ, McAllister CJ, Goldstone AP. 2010. The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood. Dev Med Child Neurol 52:e88-e93.
7. Butler MG, Bittel DC. 2007. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Genet A 143:415-421.
8. Butler MG, Bittel DC, Talebizadeh Z. 2004. Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 17:1177-1184.
9. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. 2012. Prader-Willi syndrome. Genet Med 14:10-26.
10. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schumann A, Szanto I, Tschop MH, Rohner-Jeanrenaud F. 2006. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116:1983-1993.
11. Cummings DE. 2006. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 89:71-84.
12. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS. 2002. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643-644.
13. De Waele K, Ishkanian SL, Bogarin R, Miranda CA, Ghatei MA, Bloom SR, Pacaud D, Chanoine J-P. 2008. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. Eur J Endocrinol 159:381-388.
14. Dezaki K, Hosoda H, Kakei M, Hashiguchi S, Watanabe M, Kangawa K, Yada T. 2004. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells implication in the glycemic control in rodents. Diabetes 53:3142-3151.
15. Di Francesco V, Zamboni M, Zoico E, Mazzali G, Dioli A, Omizzolo F, Bissoli L, Fantin F, Rizzotti P, Solerte SB, Micciolo R, Bosello O. 2006. Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: Another reason for the "anorexia of aging". Am J Clin Nutr 83:1149-1152.
16. Eiholzer U, Blum WF, Molinari L. 1999. Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr 134:222-225.
17. Erdie-Lalena CR, Holm VA, Kelly PC, Frayo RS, Cummings DE. 2006. Ghrelin levels in young children with Prader-Willi syndrome. J Pediatr 149:199-204.
18. Feigerlová E, Diene G, Conte-Auriol F, Molinas C, Gennero I, Salles J-P, Arnaud C, Tauber M. 2008. Hyperghrelinemia precedes obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 93:2800-2805.
19. Fidanci K, Meral C, Süleymanoğlu S, Pirgon O, Karademir F, Aydinöz S, Ozkaya H, Gültepe M, Göçmen I. 2010. Ghrelin levels and postnatal growth in healthy infants 0-3 months of age. J Clin Res Pediatr Endocrinol 2:34-38.
20. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395:763-770.
21. Goldstone AP, Holland AJ, Butler JV, Whittington JE. 2012. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Int J Obes (Lond) 36:1564-1570.
22. Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, Grossman AB, Korbonits M. 2005. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab 90:2681-2690.
23. Haqq AM, Farooqi IS, apos O, rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ. 2003. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174-178.
24. Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, Yanovski JA, Purnell JQ, Freemark M. 2008a. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) 69:911-920.
25. Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, Yanovski JA, Purnell JQ, Freemark M. 2008b. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) 69:911-920.
26. Hauffa BP, Haase K, Range IM, Unger N, Mann K, Petersenn S. 2007. The effect of growth hormone on the response of total and acylated ghrelin to a standardized oral glucose load and insulin resistance in children with Prader-Willi syndrome. J Clin Endocrinol Metab 92:834-840.
27. Hauffa BP, Petersenn S. 2009. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children. Clin Endocrinol (Oxf) 71:155-156.
28. Iñiguez G, Ong K, Peña V, Avila A, Dunger D, Mericq V. 2002. Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age. J Clin Endocrinol Metab 87:5830-5833.
29. Kalra SP, Ueno N, Kalra PS. 2005. Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action. J Nutr 135:1331-1335.
30. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. 2000. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141:4797-4800.
31. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660.
32. Kojima M, Kangawa K. 2010. Ghrelin: More than endogenous growth hormone secretagogue. Ann N Y Acad Sci 1200:140-148.
33. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. 2004. Ghrelin-a hormone with multiple functions. Front Neuroendocrinol 25:27-68.
34. Marzullo P, Verti B, Savia G. 2004. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 89:936-939.
35. Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold J-A, Kimonis V, Dykens E, Butler MG, Shuster JJ, Driscoll DJ. 2011. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A 155:1040-1049.
36. Nakai Y, Hosoda H, Nin K, Ooya C, Hayashi H. 2003. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol 149:R1-R3.
37. Perez-Tilve D, Heppner K, Kirchner H, Lockie SH, Woods SC, Smiley DL, Tschop M, Pfluger P. 2011. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J 25:2814-2822.
38. Sahin H, Erener T, Erginoz E, Vural M, Ilikkan B, Kavuncuoglu S, Yildiz H, Perk Y. 2012. The relationship of active ghrelin levels and intrauterine growth in preterm infants. Eur J Endocrinol 166:399-405.
39. Scerif M, Goldstone AP, Korbonits M. 2011. Ghrelin in obesity and endocrine diseases. Mol Cell Endocrinol 340:15-25.
40. Steculorum SM, Bouret SG. 2011. Developmental effects of ghrelin. Peptides 32:2362-2366.
41. Swaab DF, Purba JS, Hofman MA. 1995. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: A study of five cases. J Clin Endocrinol Metab 80:573-579.
42. Tan TM-M, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP. 2004. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 89:4162-4165.
43. Tauber Me, Conte Auriol, Fco Moulin, Molinas C, Delagnes Ver, Salles J-P. 2004. Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: A pathophysiological hypothesis. Horm Res 62:49-54.
44. van der Klaauw AA, Keogh JM, Henning E, Blackwood A, Haqq AM, Purnell JQ, Farooqi IS. 2013. Postprandial total ghrelin suppression is modulated by melanocortin signaling in humans. J Clin Endocrinol Metab 98:E288-E292.
45. van der Lely AJ, Tschöp M, Heiman ML, Ghigo E. 2004. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457.
46. Wren AM, Bloom SR. 2007. Gut hormones and appetite control. Gastroenterology 132:2116-2130.